Skip to content
Immunai homepage
Main Navigation
  • Solutions
  • Platform
  • Company
  • Careers
  • Media
    • Podcasts
    • Video
  • Newsroom
    • Articles
    • Press Releases
    • Publications
Secondary Navigation
  • Contact
Mobile Navigation
  • Solutions
  • Platform
  • Company
  • Careers
  • Media
    • Podcasts
    • Video
  • Newsroom
    • Articles
    • Press Releases
    • Publications
  • Contact
  • All
  • Articles
  • Podcasts
  • Press Releases
  • Publications
  • Video

Articles (37)

Articles
04/11/2024

Improving drug development with a vast map of the immune system

Articles
03/19/2024

The best investment opportunities in AI for health care right now

Articles
01/21/2024

Israel’s Immunai could be the secret weapon to faster drug approvals

Articles
10/27/2021

Koch leads mammoth $215M infusion into AI startup boasting ‘largest database’ of immune cells

Articles
10/27/2021

Immunai Raises $215 Million to Accelerate Development of Its Immune-First Drug Actuary Platform

Articles
09/09/2021

Where AI and Immunotherapy Converge to Reprogram Immunity

Articles
09/04/2021

World Changing Ideas Awards 2021: AI and Data Finalists and Honorable Mentions

Articles
07/29/2021

Data Driven: Immunai Adds Biocuration, European Hubs with Nebion Acquisition

Prev
Next

Navigation

  • Home
  • Solutions
  • Platform
  • Company
  • Careers
  • Resources
  • Contact

Contact

430 E 29th St,
New York, NY 10016, USA
info@immunai.com

Press Inquiries

press@immunai.com

Follow Us

  • Cookie Notice
  • Privacy Policy
Copyright © 2025 Immunai

We've revised our Privacy Policy and Cookie Notice. By accepting, you agree to our updated terms and policies.

Accept
Instant Access

Please share a few details and a download link will appear below.



    Thank you! Download the PDF here.